SPRB vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

SPRB

41.0
AI Score
VS
SPRB Wins

CBIO

36.1
AI Score

Investment Advisor Scores

SPRB

41score
Recommendation
HOLD

CBIO

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SPRB CBIO Winner
Net Income -24.32M -48.12M SPRB
Operating Income -25.41M -51.09M SPRB
ROE -451.5% -29.5% CBIO
ROA -158.8% -26.3% CBIO
Total Assets 15.31M 182.76M CBIO
Cash 10.67M 171.59M CBIO
Current Ratio 1.54 9.66 CBIO

Relative Price Performance (Last 90 Days)

SPRB 1M: +14.1% · 3M: +9.4% CBIO 1M: +18.1% · 3M: +5.8%

Current Technical Phase

SPRB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $53.70

CBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 58

RSI (14): 58.0 · Price: $19.41

Fundamentals Snapshot

Metric SPRB CBIO
Market Cap
Forward P/E 6.6 -7.4
Trailing P/E
Revenue (TTM)
Revenue Growth -0.8% 0.0%
Gross Margin -32.9% 1.0%
Operating Margin 0.0% -14.3%
EPS -37.38 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SPRB is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.